Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma

Glioblastoma (GBM), the most common and malignant brain tumor, is classified according to its isocitrate dehydrogenase (IDH) mutation status in the 2016 World Health Organization (WHO) brain tumor classification scheme. The standard treatment for GBM is maximal resection, radiotherapy, and Temozolom...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Molecules
Main Authors: Adilijiang, Alimu, Hirano, Masaki, Okuno, Yusuke, Aoki, Kosuke, Ohka, Fumiharu, Maeda, Sachi, Tanahashi, Kuniaki, Motomura, Kazuya, Shimizu, Hiroyuki, Yamaguchi, Junya, Wakabayashi, Toshihiko, Natsume, Atsushi
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749405/
https://ncbi.nlm.nih.gov/pubmed/31443404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24173046
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki